Replies to post #35220 on Revive Therapeutics Ltd (RVVTF)

[ragstorum]

Question for me is getting to 800.
Yeah they burned through their cash going other directions, also got blindsided by Omicron I think. I want to see high-risk study participants and that review at 800.